Search


 
Results 21 - 30 of about 91 for "FDA update".

New labels warn against sharing multi-dose insulin pens ...

In an effort to reduce the risk of infection spread, the FDA recently required additional label warnings about sharing of multi-dose diabetes pen devices ...

First continuous glucose monitoring system approved to be ...

The system is the first approved to be used with other diabetes devices, such as automated insulin-dosing systems, insulin pumps, or blood glucose ...

First drug in new class approved | ACP Diabetes Monthly

The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.

New long-acting insulin drugs approved | ACP Diabetes ...

Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) were approved by the FDA on Sept. 25.

July 11, 2014 | ACP Diabetes Monthly

... FDA update. Inhaled insulin approved. Afrezza, a rapid-acting, inhaled human insulin, was recently approved by the FDA to treat diabetes in adults. ...

Olmesartan passes safety review | ACP Diabetes Monthly

The benefits of the angiotensin-receptor blocker olmesartan continue to outweigh the risks for diabetic patients, according to the FDA.

November 14, 2014 | ACP Diabetes Monthly

... a study found. FDA update. Glucose monitoring system approved specifically for critical care units. The FDA recently approved ...

May 10, 2013 | ACP Diabetes Monthly

... avoiding and treating hypoglycemia. FDA update. Single and combo diabetes drugs approved. Alogliptin (Nesina) and two ...

Incretin mimetics' effects on pancreas under investigation ...

The FDA is investigating reports of possible increased risk of pancreatitis and precancerous findings of the pancreas from incretin mimetic drugs for type ...

Aflibercept approved for diabetic retinopathy in diabetic ...

Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently ...

Result Page: < Previous  1 2 3 4 5 6 7  Next >